agilon health (AGL) Stock Forecast, Price & News

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for agilon health in the last year. There are currently 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" AGL shares.
View AGL analyst ratings or view top-rated stocks.

7 analysts have issued 12 month target prices for agilon health's stock. Their AGL share price forecasts range from $22.50 to $32.00. On average, they anticipate the company's stock price to reach $27.39 in the next twelve months. This suggests a possible upside of 54.2% from the stock's current price.
View analysts price targets for AGL or view top-rated stocks among Wall Street analysts.

agilon health's stock was trading at $16.14 at the beginning of the year. Since then, AGL shares have increased by 10.0% and is now trading at $17.76.
View the best growth stocks for 2023 here.

agilon health saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 42,520,000 shares, an increase of 5.8% from the August 31st total of 40,190,000 shares. Based on an average trading volume of 2,340,000 shares, the short-interest ratio is presently 18.2 days. Approximately 14.2% of the shares of the company are sold short.
View agilon health's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023.
View our AGL earnings forecast.

agilon health, inc. (NYSE:AGL) announced its earnings results on Thursday, August, 3rd. The company reported ($0.04) earnings per share for the quarter, missing the consensus estimate of ($0.01) by $0.03. The firm earned $1.15 billion during the quarter, compared to analyst estimates of $1.11 billion. agilon health had a negative net margin of 2.39% and a negative trailing twelve-month return on equity of 8.57%.

ETFs with the largest weight of agilon health (NYSE:AGL) stock in their portfolio include Fidelity Disruptive Medicine ETF (FMED), SPDR S&P Health Care Services ETF (XHS), iShares U.S. Healthcare Providers ETF (IHF), Renaissance IPO ETF (IPO), Fidelity Growth Opportunities ETF (FGRO) and Global X Aging Population ETF (AGNG).RiverNorth Patriot ETF (FLDZ) and

agilon health updated its third quarter 2023 earnings guidance on Thursday, August, 3rd. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.13 billion-$1.14 billion, compared to the consensus revenue estimate of $1.10 billion.

(AGL) raised $1 billion in an initial public offering on Thursday, April 15th 2021. The company issued 46,600,000 shares at a price of $20.00-$23.00 per share. J.P. Morgan, Goldman Sachs, BofA Securities, Deutsche Bank Securities and Wells Fargo Securities served as the underwriters for the IPO and William Blair, Truist Securities and Nomura were co-managers.

agilon health trades on the New York Stock Exchange (NYSE) under the ticker symbol "AGL."

Shares of AGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of AGL stock can currently be purchased for approximately $17.76.

agilon health (NYSE:AGL) has a market capitalization of $7.20 billion and generates $2.71 billion in revenue each year. The company earns $-106,550,000.00 in net income (profit) each year or ($0.21) on an earnings per share basis.

The company employs 747 workers across the globe.

The official website for the company is agilonhealth.com. The company can be reached via phone at 562-256-3800 or via email at investor.relations@agilonhealth.com.